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Antiphospholipid antibodies and subsequent thrombo-occlusive
events in patients with ischemic stroke
The APASS Investigators. JAMA 2004;291:576-84.
Conclusions: In patients with ischemic stroke, antiphospholipid anti-
bodies (lupus anticoagulant [LA] or anticardiolipin antibody [aCL]) do not
predict an increased risk for another thromboembolic or vascular occlusive
event over 2 years, nor do they predict a differential response to warfarin or
aspirin therapy.
Summary: This is a prospective study derived from participants in the
warfarin versus aspirin recurrent stroke study (WARSS). The current study,
the antiphospholipid antibodies and stroke study (APASS), tested hypoth-
eses specified prior to initiation of the WARSS. The goal was to evaluate the
effect of baseline antiphospholipid antibody positivity on late thrombo-
occlusive events in patients with ischemic stroke. The main outcome mea-
sure was a 2-year rate of the composite end point of death from any cause,
ischemic stroke, transient ischemic attack, myocardial infarction, deep ve-
nous thrombosis, pulmonary embolism, and other systemic thrombo-occlu-
sive events. Analysis was done with respect to both aCL and LA levels.
Therewere1,770APASSpatients.Ofthese,720(41%)wereantiphospho-
lipid antibody positive and 1,050 (59%) were negative. Positive antiphos-
pholipid antibody status did not confer increased risk of thrombo-occlusive
events during follow-up. This was true for patients treated with warfarin
(relative risk [RR], 0.99; 95% confidence interval [CI], 0.75-1.31; P .94)
or aspirin (RR, 0.94; 95% CI, 0.70-1.28; P  .71). The overall composite
end-point event rate in antiphospholipid antibody–positive patients was
22.2%; it was 21.8% among negative patients. Patients who were positive at
baseline for both LA and aCL tended to have a higher event rate (31.7%)
than did patients who tested negative for both LA and aCL (24.0%), (RR,
1.36; 95% CI, 0.97-1.92; P .07). There were no specific LA tests, or aCL
isotopes or titers, that conferred increased risk of thrombo-occlusive events.
Comment: Antiphospholipid antibodies are linked to an immune-
mediated coagulopathy. The data here indicate no role for antiphospholipid
antibodies in predicting subsequent vascular risk in patients with ischemic
stroke or in predicting response to aspirin or warfarin therapy. By inference,
the true role of antiphospholipid antibodies in patients with peripheral
vascular disease probably still remains to be defined.
Inhibition of experimental abdominal aortic aneurysm in the rat by use
of decoy oligodeoxynucleotides suppressing activity of nuclear factor
kb and ets transcription factors
Nakashima H, Aokin M, Miyake T, et al. Circulation 2004;109:132-8.
Conclusion: The use of a chimeric decoy active against nf-kb and ets
transcription factors inhibits progression of aneurysmal dilatation in a rat
model of abdominal aortic aneurysm (AAA).
Summary: Matrix metalloproteinases (MMPs) lead to destruction of
elastin and may play a role in aneurysm development and rupture. Transcrip-
tion factor nuclear factor (nf)-kb regulates the transcription of MMP 1, 2, 3,
and 9. The ets-1 family of transcription factors activates the transcription of
genes coding MMP 1, 3, and 9. The authors developed a chimeric decoy
oligodeoxynucleotide (ODN) to inhibit both nf-kb and ets transcription
factors. The goal was to decrease aneurysmal degeneration in a rat model
through delivery of ODN and subsequent inhibition of MMP expression.
AAAs were induced in rats by transient aortic profusion with elastase.
Transfection of decoy ODN was performed by wrapping a delivery sheet
containing ODN around the aorta. At 7 days, using a gel-mobility shift assay,
both ets and nf-kb binding activities were inhibited by the decoy. Animals
treated with the chimeric decoy ODN had significantly less progression of
AAA enlargement at 4 weeks than control animals. This was accompanied by
a reduction of MMP expression. Scrambled decoy ODN had no effect.
Comment: These data suggest a potentially important role in aneu-
rysm development for transcription factors nuclear factor (nf)-kb and ets-1.
The chimeric decoy is able to bind to free nf-kb and ets and thereby prevent
activation of genes dependent upon these transcription factors. This is truly
exciting research targeting inhibition of degenerative processes at the ge-
netic level.
Poor control of risk factors for vascular disease among adults with
previously diagnosed diabetes
Saydah SH, Fradkin J, Cowie CC. JAMA 2004;291:335-42.
Conclusion: Only 7.3% of adults with diabetes meet recommended
goals for hemoglobin (HbA1c) levels, blood pressure, and total cholesterol.
Summary: The American Diabetes Association (ADA) has standards of
medical care for individuals with diabetes. The aim is to reduce vascular
complications of diabetes. The ADA goal for glycemic control is HbA1c
levels 7%. The goal for blood pressure control is a systolic pressure 130
mm Hg and a diastolic pressure 80 mm Hg. The national cholesterol
education program adult treatment panel sets a goal of a total cholesterol
level of 200 mg/dL.
The authors analyzed adultsage 20 years with known and previously
diagnosed diabetes who had participated in 2 National Health and Nutrition
Examination Surveys (NHANES). The first survey was conducted between
1988 and 1994 and the second from 1999 to 2000. In the latter survey, only
37% of participants achieved a target goal of HbA1c level7%. Only 35.8%
of participants achieved a target of a systolic blood pressure 130 mm Hg
and a diastolic pressure80 mm Hg. With respect to hemoglobin A1c levels
and blood pressure control, there was no improvement from the 1988-1994
survey to the 1999-2000 survey. In the first NHANES survey 66.1% had a
total cholesterol level 200 mg/dL, while in the second NHANES survey
51.8% had a total cholesterol200 mg/dL, (P .001). Overall, only 7.3%
(95% confidence interval, 2.8-11.9) of adults in the second NHANES survey
met recommended goals of HbA1c, blood pressure, and total cholesterol.
Comment: The study indicates that, despite widespread publicity
regarding the importance of glycemic, lipid, and blood pressure control in
patients with diabetes, the US health care system has not worked well to
improve glycemic and blood pressure control in people with diabetes. While
lipid levels have improved, they are still unacceptable. Clearly, further public
health efforts are urgently needed to control risk factors for vascular disease
among people with diabetes.
Does supervised exercise offer adjuvant benefit over exercise advice
alone for the treatment of intermittent claudication? A randomized
trial
Cheetham BR; Burgess L; Ellis N; et al. Eur J Vasc Endovasc Surg 2004;
27:17-23.
Conclusion: A weekly supervised exercise class for 6 months provides
greater improvement in patient symptoms, walking distance, and quality of
life than does written and verbal exercise advice alone.
Summary: The study consisted of 59 patients with intermittent clau-
dication. The patients were randomized to receive just advice to exercise
(n  30), or to receive advice to exercise along with a once-a-week 45-
minute supervised exercise/motivation class (n  29). The patients were
evaluated at baseline and at 6-month follow-up. Evaluation included a
short-form quality of life questionnaire (SF-36), the Charing Cross symp-
tom-specific claudication questionnaire (CCCQ), and treadmill walking
distance at 3.5km/h with a 12% grade.
The mean age of the patients was 68 years. At 6-month follow-up, the
supervised exercise group improved treadmill walking by 129%. The advice-
alone group improved treadmill walking by 69% (P  .001). Improvement
was maintained at 9- and 12- month assessments. There were no significant
differences between the groups with regard to follow-up SF 36 scores
compared with baseline. By 9 months the advice-only group’s CCCQ score
improved 16% from baseline while the supervised-exercise group had a 43%
improvement over baseline (P  .05). At 6 months, the supervised-exercise
group reported a higher frequency of 30-minute walks compared with the
advice-only group.
Comment: The data indicate the power of continual reinforcement in
a structured program to maximize the beneficial effects of exercise therapy in
patients with intermittent claudication. Patients who undergo interventional
or operative treatment of claudication are rarely normalized. It would be
interesting to see if supervised exercise programs in patients who undergo
angioplasty or surgery for claudication would also improve overall quality of
life and walking distance over that achieved with intervention alone.
Transient Ischemic Attacks Before Ischemic Stroke: Preconditioning
the Human Brain? A Multicenter Magnetic Resonance Imaging Study
Wegener S, Gottchalk B, Jobanobic B, et al. Stroke 2004;35:616-21.
Conclusion: Stroke patients with and without prodromal transient
ischemic attacks (TIAs) have similar profusion lesions, but patients with
prodromal transient ischemic attacks have smaller final infarct sizes, suggest-
ing a neuroprotective effect of TIAs in patients with subsequent stroke.
Summary: The authors studied 65 patients with first-ever ischemic
strokes who were admitted to 4 university hospitals in Germany. Patients
were examined with diffusion and profusion weighted magnetic resonance
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